# ANALYSIS / MEMORANDUM ## 1. Express Warranty and Other Contractual Obligations ### A. “Rated throughput: 300 vials per minute” is likely an express warranty Under the stated Commercial Code rule, a factual description or specification that becomes part of the basis of the bargain creates an express warranty. The contract’s “Rated throughput: 300 vials per minute” is not mere sales puffing; it is a specific, written performance specification. LumaBio therefore has a strong argument that PrecisionFill contractually warranted that the line would have a rated throughput of 300 vpm, not merely that it would pass a 285-vpm acceptance test. The 285-vpm site acceptance standard does not necessarily erase the 300-vpm warranty. The better reading is: - **300 vpm** = the warranted/rated capacity of the line. - **285 vpm** = the minimum threshold required for site acceptance. Those two numbers can coexist. The acceptance test is a floor for acceptance; it is not necessarily a cap on PrecisionFill’s warranty obligations. LumaBio can argue that PrecisionFill warranted both: 1. the line would pass the four-hour acceptance test, and 2. the line would conform to the written specifications, including the 300-vpm rated throughput. If the line, after the humidity issue was fixed and the software patch was installed, still “rarely exceeded 290” even with compliant film, LumaBio has a credible breach-of-express-warranty claim on the 300-vpm term. PrecisionFill will argue that “rated” means “nameplate” or “ideal maximum,” not an actual sustained guarantee, and that the parties deliberately made 285 the only enforceable acceptance standard. That is a serious defense, especially because LumaBio’s project leader internally wrote that the contract “only guarantees a 285 acceptance test.” LumaBio’s own internal email will be used against it. ### B. The software defect was also a breach of the 12-month warranty The feed-control software problem caused the line to run at only 270 vpm even after the humidity was corrected. That is a defect in materials/workmanship or at least a failure to conform to the written specifications. PrecisionFill had a contractual duty to repair or replace. It did deliver a patch, but the patch came six weeks later and did not bring the line to 300 vpm. So, separately from the 300-vpm issue, LumaBio can say PrecisionFill breached its warranty obligations until the software problem was cured. If the cure was timely and effective, the breach is limited to the delay/downtime. If the cure was not effective because the line still does not meet 300, the breach continues. --- ## 2. The Pre-Contract Email: Admissibility and Fraud ### A. The email likely is not admissible as a contractual warranty The final written contract: - contains a merger clause, - says it is the complete agreement, - says LumaBio did not rely on statements not contained in the contract, - contains an exclusive repair/replacement remedy, - and otherwise defines the parties’ obligations. Under the parol-evidence rules stated above, a completely integrated writing excludes prior or contemporaneous agreements that contradict it. The VP’s pre-contract email promising “300 all day” and “make you whole” adds obligations beyond the written contract and conflicts with: - the 285-vpm acceptance test, - the exclusive repair/replacement remedy, - the consequential-damages exclusion, - and the no-reliance clause. So LumaBio cannot likely use the email to create an additional express warranty or an additional “take it back and make you whole” remedy. LumaBio’s project leader also internally acknowledged that the 300 commitment was not in the contract, yet signed anyway. That will be powerful evidence against treating the email as a contract term. ### B. The email may still be independently actionable as fraud The no-reliance and merger clauses do not automatically bar fraud. Under the stated rules, they are relevant to reliance but do not automatically defeat fraud based on an intentionally false factual representation about information peculiarly within the speaker’s knowledge. LumaBio’s fraud claim would be based on: - **False statement:** “This line will run 300 all day in your facility on your current film.” - **Falsity:** PrecisionFill’s internal engineering chats before signing said the architecture would “probably top out around 288” with LumaBio’s film unless the feeder was redesigned. - **Knowledge/recklessness:** One engineer said, “Do not put 288 in writing,” which suggests PrecisionFill knew the 300 statement was unsupportable but wanted to avoid putting the real number in writing. - **Intent to induce:** The email was sent before signing to assure LumaBio. - **Reasonable reliance:** LumaBio received the email and relied on the specific factual assurance about the line’s capability. The no-reliance clause and LumaBio’s internal “contract only guarantees 285” email weaken this, but the rule says those facts do not automatically defeat fraud. - **Loss:** The line did not run 300 all day and LumaBio suffered production losses. The fraud claim is not certain, but it is viable. It is also important because the contract says its liability limitations do not apply to fraud. If LumaBio can prove fraud, it may escape the consequential-damages exclusion and the liability cap. --- ## 3. Significance of Acceptance, the Certificate, and Subsequent Conduct ### A. LumaBio accepted the line LumaBio signed a certificate stating: > “Site acceptance completed, subject to punch-list items and sustained production validation.” That is very likely an acceptance under the stated rule. A buyer accepts when, after a reasonable opportunity to inspect, it signifies acceptance. Even if the phrase “subject to punch-list items” reserved some rights, LumaBio did not effectively reject the line. It then used the line for eight months and only later complained. The certificate also matters because PrecisionFill will argue: - the line passed the contract’s four-hour acceptance test (287 vpm, 2.6% rejection, at 42% humidity); - LumaBio signed the certificate; and - LumaBio therefore got the benefit of the acceptance standard it bargained for. LumaBio’s best response is that acceptance does not waive warranty damages. A buyer can accept goods and still sue for breach of warranty. So the certificate forecloses rejection and revocation, but not a damages claim. ### B. Rejection is no longer available LumaBio had a reasonable opportunity to inspect. It signed the certificate and used the line. It did not make an effective rejection. Rejection is therefore unavailable. ### C. Revocation is likely unavailable too Revocation of acceptance requires: - a nonconformity that substantially impairs the value of the goods, - acceptance induced by difficulty discovering the defect or by the seller’s assurances, - revocation within a reasonable time, - and no substantial change in the condition of the goods not caused by the defect. LumaBio has some arguments: - the feed-control software defect was hidden; - PrecisionFill assured performance; - the line did not meet 300; - and continued use may have been necessary to avoid serious loss. But LumaBio used the line in ordinary production for eight months. That is not the kind of limited use permitted merely to avoid serious loss. It also never clearly revoked after discovering the continuing problem. So revocation is likely lost. --- ## 4. Notice of Breach The rule requires the buyer to notify the seller of breach within a reasonable time after discovering or should have discovered it. LumaBio sent a formal breach notice 75 days after sustained production began. That is probably sufficient, or at least excusable, because: - PrecisionFill’s technicians were working on the performance problem from the first week; - PrecisionFill had actual knowledge of the problem; - PrecisionFill did not suffer prejudice from the delay; - and 75 days is not obviously unreasonable while the parties were trying to fix the line. The rule itself says that actual seller knowledge may affect whether formal notice was sufficient. LumaBio should nevertheless document that it gave PrecisionFill notice of the specific claimed breach and not just notice of operational problems. --- ## 5. Did the Repair/Replacement Remedy Fail of Its Essential Purpose? The contract made repair or replacement the exclusive remedy. Under the stated rules, an exclusive repair/replacement remedy fails if the seller cannot or will not provide an effective cure within a reasonable time. Here: - PrecisionFill discovered the feed-control software problem; - it took six weeks to deliver a patch; - after the patch, the line ran at 286–289 vpm and occasionally reached 300 for only minutes; - with compliant film, it still rarely exceeded 290 vpm. If the 300-vpm term is enforceable as a warranty, then PrecisionFill has not provided an effective cure. The line still does not meet the promised rated throughput. The repair remedy may therefore have failed of its essential purpose. But that does **not** automatically open the door to consequential damages. The contract expressly says: > The consequential-damage exclusion remains effective even if the exclusive remedy fails. The stated rule confirms that a separate consequential-damages exclusion remains enforceable unless unconscionable or made dependent on the exclusive remedy. That clause is between sophisticated commercial parties and is likely enforceable. So even if the repair remedy failed, LumaBio cannot recover lost profits or customer penalties unless the fraud exception applies. --- ## 6. Recoverable Damages ### A. Direct damages LumaBio can likely recover direct damages measured by the difference between the value of the line as warranted and the value of the line as delivered, or the reasonable cost to cure the defect. If the line was supposed to run at 300 vpm, and in fact performs at roughly 286–289 vpm with compliant film, the direct damage would be: - the cost of redesigning/upgrading the feeder or other components to reach 300 vpm, or - the diminished market value of the line, shown through expert testimony. These damages are recoverable in principle, subject to LumaBio’s duty to mitigate and prove causation. ### B. Lost profits, lost customer order, overtime, temporary labor, and expedited shipping These are the problem for LumaBio. The contract expressly excludes: - lost profits, - lost production, - customer penalties, - and other consequential damages. PrecisionFill knew LumaBio intended to use the line for the major customer, which might make those losses foreseeable. But foreseeability does not override an explicit consequential-damages exclusion. Between sophisticated parties, such exclusions are generally enforced. Overtime, temporary labor, and expedited shipping are likely consequential damages because they are costs incurred because of lost production and delay. They are not simply the cost of repairing the line. Even if the repair remedy failed, the contract says the consequential-damages exclusion remains effective. Therefore, unless LumaBio proves fraud, gross negligence, or willful misconduct—and the contract’s exclusions do not apply to those claims—those damages are probably not recoverable. If LumaBio proves fraud, the limitations clause in the contract says the limitations do not apply to fraud. Then LumaBio may recover consequential damages if it can prove: - causation, - foreseeability, - reasonable certainty, - and mitigation. ### C. Liability cap For ordinary contract/warranty claims, PrecisionFill’s total liability is capped at the $4.8 million purchase price. That cap likely applies unless the fraud/gross negligence exception applies. --- ## 7. Withholding the Final $900,000 Installment The rule allows a buyer to deduct damages from an unpaid price after notifying the seller of its intention to do so. LumaBio withheld the final $900,000. That was risky unless it gave PrecisionFill clear notice that it was withholding/offsetting damages. A formal breach notice may not be enough if it did not say LumaBio intended to deduct damages from the price. LumaBio should send a clear notice now, if it has not already: > “LumaBio gives notice that it is withholding/deducting $______ from the final installment as damages for PrecisionFill’s breach.” If LumaBio’s damages are proven and equal at least $900,000, the withholding is proper. If its damages are less, or if the damages are excluded by the contract, LumaBio will owe the balance, possibly with interest. Given the contract language favoring PrecisionFill on consequential damages, LumaBio should not treat the $900,000 as automatically “free.” It should be able to prove that much in allowed direct damages or fraud damages. --- ## 8. Spoliation / Deleted Telemetry LumaBio sent an email on day 25 stating it was “considering all contractual and legal remedies.” That likely made litigation reasonably anticipated. PrecisionFill should have suspended its automatic deletion of raw diagnostic telemetry. It did not. The raw telemetry was overwritten on day 30. PrecisionFill preserved only summary reports. Under the stated rule: - a party must preserve relevant evidence when litigation is reasonably anticipated; - negligent loss may justify measures curing proven prejudice; - but an adverse inference requires intent to deprive the opposing party of evidence. Here, there is no evidence that PrecisionFill intentionally deleted the telemetry to hide it. The automatic system overwrote it. So LumaBio probably cannot get an adverse-inference instruction. LumaBio can, however, ask the court for lesser sanctions: - allow LumaBio to argue that the missing telemetry is relevant; - preclude PrecisionFill from denying certain facts if summaries are inadequate; - shift costs; - or give a curative instruction that does not go as far as an adverse inference. The deletion is not LumaBio’s strongest argument, but it adds pressure and shows PrecisionFill was not careful with evidence once litigation was threatened. --- ## 9. PrecisionFill’s Strongest Defenses ### A. Contract language: 285 vpm is the only guaranteed throughput PrecisionFill will argue that the contract specifically defined “site acceptance” at 285 vpm, not 300 vpm. It will say: - “Rated throughput: 300” is a nameplate/ideal rating; - the acceptance test is the operative guarantee; - LumaBio passed the test; - LumaBio signed the certificate; - therefore the line conforms. This is the strongest defense. LumaBio’s own internal email saying the contract “only guarantees a 285 acceptance test” makes it worse. **LumaBio response:** The 300-vpm term would be surplusage if it meant nothing. The warranty says the line will conform to the written specifications, and “rated throughput: 300” is a written specification. The 285-vpm acceptance test is just the minimum threshold to accept delivery. ### B. Humidity The line performed badly during the first three weeks because LumaBio’s HVAC project was incomplete and humidity was 52–60%, outside the contract’s 35–45% range. PrecisionFill will argue those failures were LumaBio’s fault. **LumaBio response:** After the HVAC was fixed, the line still ran at only 270 vpm until the software patch. Even after the patch, it did not reach 300. So humidity explains part of the problem, but not the entire breach. ### C. Film variance 18% of LumaBio’s film lots exceeded Schedule B. LumaBio had pre-contract QC data showing this but never gave it to PrecisionFill. PrecisionFill will argue: - the contract only required performance with compliant film; - LumaBio used noncompliant film; - the line performed worse when noncompliant film was used; - therefore LumaBio caused much of the problem. **LumaBio response:** Even with compliant film, the line “rarely exceeded 290.” So the film variance does not explain the failure to reach 300. ### D. Merger clause / no-reliance clause PrecisionFill will rely heavily on the written contract’s: - merger clause, - no-reliance clause, - exclusive repair remedy, - warranty disclaimer, - consequential-damages exclusion, - and liability cap. These clauses are strong. **LumaBio response:** These clauses do not bar a fraud claim based on an intentionally false representation about the line’s technical capability, which was peculiarly within PrecisionFill’s knowledge. ### E. Notice and mitigation PrecisionFill will argue: - LumaBio waited 75 days to send a formal breach notice; - LumaBio continued using the line for eight months; - LumaBio failed to mitigate by rejecting/returning the line or by using compliant film; - the claimed lost customer order is speculative. **LumaBio response:** - PrecisionFill knew of the problem and was working on it; - continued use was necessary to avoid shutting down production; - the line was accepted, so rejection was no longer available; - LumaBio’s damages can be shown with expert testimony. --- ## 10. Recommendation: Litigate, Pay, Demand Engineering Work, or Settle? LumaBio should **not** simply pay the $900,000, and it should **not** file immediate litigation unless settlement fails. ### Recommended path: 1. **Do not pay the withheld $900,000 yet.** But send a clear Rule 9 notice that LumaBio is withholding/deducting damages from the final installment. If possible, consider placing the $900,000 in escrow to avoid interest/breach risk while preserving leverage. 2. **Demand additional engineering work.** Demand that PrecisionFill redesign/repair the feeder and related components so the line sustains 300 vpm on Schedule B–compliant film at 35–45% humidity. Also demand an extended warranty for the redesigned components. 3. **Use the fraud evidence as settlement leverage.** PrecisionFill’s internal chats are damaging. They show that at least some PrecisionFill personnel knew the line would “probably top out around 288” with LumaBio’s film, while sales was telling LumaBio 300. Even if LumaBio’s contract damages are capped/excluded, the fraud claim threatens PrecisionFill with consequential damages and a path around the contract limitations. 4. **Negotiate a commercial settlement.** The likely best outcome is: - PrecisionFill performs the engineering upgrade to get closer to 300 vpm; - LumaBio retains the $900,000 as a price adjustment/offset; - both parties exchange releases; - or PrecisionFill pays a cash amount and LumaBio releases all claims. 5. **Litigate only if settlement fails and the fraud evidence holds up.** LumaBio’s strongest legal path is: - breach of express warranty on the 300-vpm term; - fraudulent inducement based on the pre-contract email and internal chats; - not rejection/revocation, which are likely time-barred. ### Practical bottom line LumaBio has a credible breach claim because the contract says “rated throughput: 300 vpm,” and the line does not perform at that level even with compliant film. But PrecisionFill has powerful contract defenses, including the 285 acceptance standard, the merger/no-reliance clause, the consequential-damages exclusion, and the liability cap. The best move is to **negotiate a settlement while preserving the fraud claim as leverage**: continue withholding the final installment, demand an engineering fix, and, if no acceptable resolution is reached, litigate fraud and breach of express warranty.